Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-26

Clinical Trial Update: Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Hylo-Dual to Patanol in children with seasonal allergic conjunctivitis and vernal conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hylo-Dual
  • Patanol (olopatadine hydrochloride)

Snippet

Sponsor: Michael Marchand, MD | Conditions: Conjunctivitis, Allergic, Conjunctivitis, Vernal | Phase 4 | Status: UNKNOWN